Authors:
Laver, JH
Mahmoud, H
Pick, TE
Hutchinson, RE
Weinstein, HJ
Schwenn, M
Weitzman, S
Murphy, SB
Ochoa, S
Shuster, JJ
Citation: Jh. Laver et al., Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: A Pediatric Oncology Group study, LEUK LYMPH, 42(3), 2001, pp. 399-405
Citation: Ba. Bell et al., A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study, MED PED ONC, 37(2), 2001, pp. 103-107
Authors:
Dahl, GV
Lacayo, NJ
Brophy, N
Dunussi-Joannopoulos, K
Weinstein, HJ
Chang, MR
Sikic, BI
Arceci, RJ
Citation: Gv. Dahl et al., Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia, J CL ONCOL, 18(9), 2000, pp. 1867-1875
Authors:
Grupp, SA
Stern, JW
Bunin, N
Nancarrow, C
Ross, AA
Mogul, M
Adams, R
Grier, HE
Gorlin, JB
Shamberger, R
Marcus, K
Neuberg, D
Weinstein, HJ
Diller, L
Citation: Sa. Grupp et al., Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma, J CL ONCOL, 18(13), 2000, pp. 2567-2575
Authors:
Larsen, E
Bramson, RT
Ebb, DH
de Leval, L
Weinstein, HJ
Citation: E. Larsen et al., A seven-year-old girl with the superior vena cava syndrome after treatmentfor a peripheral rhabdomyosarcoma. Precursor T-lymphoblastic lymphoma and early myeloid dysplastic syndrome after chemotherapy for peripheral rhabdomyosarcoma., N ENG J MED, 343(17), 2000, pp. 1249-1257
Authors:
McLean, TW
Hertel, C
Young, ML
Marcus, K
Schizer, MA
Gebhardt, M
Weinstein, HJ
Perez-Atayde, A
Grier, HE
Citation: Tw. Mclean et al., Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: The Dana-Farber Cancer Institute/Children's Hospital experience, J PED H ONC, 21(6), 1999, pp. 486-493
Authors:
Parsons, SK
Gelber, S
Cole, BF
Ravindranath, Y
Ogden, A
Yeager, AM
Chang, M
Shuster, J
Weinstein, HJ
Gelber, RD
Citation: Sk. Parsons et al., Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821, J CL ONCOL, 17(7), 1999, pp. 2144-2152
Authors:
Bloom, BJ
Zukerberg, LR
Bramson, RT
Weinstein, HJ
Pasternack, MS
Newton, AW
Citation: Bj. Bloom et al., A nine-year-old girl with fever and cervical lymphadenopathy - Lupus lymphadenitis consistent with the presence of systemic lupus erythematosus., N ENG J MED, 340(19), 1999, pp. 1491-1497
Authors:
Taub, JW
Huang, X
Matherly, LH
Stout, ML
Buck, SA
Massey, GV
Becton, DL
Chang, MN
Weinstein, HJ
Ravindranath, Y
Citation: Jw. Taub et al., Expression of chromosome 21-localized genes in acute myeloid leukemia: Differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin, BLOOD, 94(4), 1999, pp. 1393-1400
Authors:
Raimondi, SC
Chang, MN
Ravindranath, Y
Behm, FG
Gresik, MV
Steuber, CP
Weinstein, HJ
Carroll, AJ
Citation: Sc. Raimondi et al., Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group Study - POG 8821, BLOOD, 94(11), 1999, pp. 3707-3716